A Study of AeroVanc for the Treatment of MRSA Infection in CF Patients
This study is a multi-center, randomized phase III study to evaluate the clinical effectiveness of AeroVanc in persistent MRSA in patients with Cystic Fibrosis.
Cystic Fibrosis
Learn about the latest updates and changes to elective, non-urgent and non-emergency procedures.
Vaccination Updates | Testing for COVID-19 | Safety & Appointments | Help Stop the Spread
This study is a multi-center, randomized phase III study to evaluate the clinical effectiveness of AeroVanc in persistent MRSA in patients with Cystic Fibrosis.